Neurology
Thomas Kaley, M.D,
Chief of Neuro-Oncology and Cancer Neurology, Memorial Sloan Kettering Cancer Center
Dr. Thomas J. Kaley is Chief of Neuro-Oncology and Cancer Neurology at Memorial Sloan Kettering Cancer Center (MSK) in New York, NY, where he specializes in treating adult patients with primary central nervous system (CNS) cancers and brain tumors. His clinical focus includes glioblastomas, gliomas (such as low-grade gliomas and anaplastic gliomas), meningiomas, ependymomas, and other rare tumors, as well as neurological complications of cancer. He also manages conditions like hypothalamus cance
23+
Years in Practice
Credentials
Board Certifications
- Neurology (American Board of Psychiatry and Neurology)
Education & Training
- NYU Grossman School of Medicine — M.D., 2003
- NYU Medical Center — Residency, Neurology, 2004-2007
- Neurology Fellowship - Memorial Sloan Kettering Cancer Center
Peer Recognition
- Castle Connolly — America's Top Doctors
2019-2026 (8 years)
2019-2023 (5 years)
2019, 2021-2025 (6 years)
2019, 2021-2025 (6 years)
Recognition & Leadership
Leadership Roles
- Chief of Neuro-Oncology and Cancer Neurology Service, Memorial Sloan Kettering Cancer Center
- Vice Chair for Clinical Research, Department of Neurology, Memorial Sloan Kettering Cancer Center
- Chair of the Institutional Review Board (IRB-C), Memorial Sloan Kettering Cancer Center
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Sturdy Memorial Hospital
- Memorial Hospital for Cancer and Allied Diseases
- NewYork-Presbyterian Hospital
- Memorial Sloan Kettering Cancer Center
- NYC Health + Hospitals/Bellevue
Languages
English
Experience
23+ years in practice